Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carla L Zema

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Health Care Financing Review|November 6, 2014
Evidence of Innovative Uses of Performance Measures Among PurchasersCarla L Zema, Lisa Rogers
JAMA Dermatology|August 10, 2022
Understanding Flares in Patients With Generalized Pustular Psoriasis Documented in US Electronic Health RecordsCarla L Zema, Wendell C Valdecantos, Jonathan Weiss, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|July 4, 2012
Consumer assessment of healthcare providers and systems surgical care survey: benefits and challengesKristine A Schulz, John S Rhee, Jean M Brereton, et al.
ESC Heart Failure|February 13, 2025
Treatment patterns, outcomes and healthcare resource utilization of obstructive hypertrophic cardiomyopathy in EnglandFaizel Osman, Carla L Zema, Michael Hurst, et al.
Journal of Opioid Management|February 1, 2014
Physician management of moderate-to-severe acute pain: results from the Physicians Partnering Against Pain (P³) studyBill H McCarberg, Aarti A Patel, Carmela J Benson, et al.
Current Medical Research and Opinion|July 16, 2025
Development of the modified Daily Symptom Diary (mDSD): a patient-reported outcome measure of dysphagia for eosinophilic esophagitisElizabeth D Bacci, Christina M Charriez, Christina Slota, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|October 27, 2025
Clinical and economic burden associated with symptomatic and asymptomatic obstructive hypertrophic cardiomyopathy in GermanyFarbod Sedaghat-Hamedani, Carla L Zema, Michael Schultze, et al.
Journal of Medical Economics|June 8, 2026
A global model for symptomatic obstructive hypertrophic cardiomyopathy to assess the cost-effectiveness of mavacamten: results from a Dutch societal perspectiveVarun Ektare, Claire Simons, Kasper Johannesen, et al.
NEJM Evidence|September 23, 2025
Cendakimab in Adults and Adolescents with Eosinophilic EsophagitisEvan S Dellon, Christina M Charriez, Sandra Zhang, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Health Care Financing Review|November 6, 2014
Evidence of Innovative Uses of Performance Measures Among PurchasersCarla L Zema, Lisa Rogers
JAMA Dermatology|August 10, 2022
Understanding Flares in Patients With Generalized Pustular Psoriasis Documented in US Electronic Health RecordsCarla L Zema, Wendell C Valdecantos, Jonathan Weiss, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|July 4, 2012
Consumer assessment of healthcare providers and systems surgical care survey: benefits and challengesKristine A Schulz, John S Rhee, Jean M Brereton, et al.
ESC Heart Failure|February 13, 2025
Treatment patterns, outcomes and healthcare resource utilization of obstructive hypertrophic cardiomyopathy in EnglandFaizel Osman, Carla L Zema, Michael Hurst, et al.
Journal of Opioid Management|February 1, 2014
Physician management of moderate-to-severe acute pain: results from the Physicians Partnering Against Pain (P³) studyBill H McCarberg, Aarti A Patel, Carmela J Benson, et al.
Current Medical Research and Opinion|July 16, 2025
Development of the modified Daily Symptom Diary (mDSD): a patient-reported outcome measure of dysphagia for eosinophilic esophagitisElizabeth D Bacci, Christina M Charriez, Christina Slota, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|October 27, 2025
Clinical and economic burden associated with symptomatic and asymptomatic obstructive hypertrophic cardiomyopathy in GermanyFarbod Sedaghat-Hamedani, Carla L Zema, Michael Schultze, et al.
Journal of Medical Economics|June 8, 2026
A global model for symptomatic obstructive hypertrophic cardiomyopathy to assess the cost-effectiveness of mavacamten: results from a Dutch societal perspectiveVarun Ektare, Claire Simons, Kasper Johannesen, et al.
NEJM Evidence|September 23, 2025
Cendakimab in Adults and Adolescents with Eosinophilic EsophagitisEvan S Dellon, Christina M Charriez, Sandra Zhang, et al.
Pageof 1